8.70
price up icon2.11%   0.18
after-market After Hours: 8.69 -0.010 -0.11%
loading
Novavax Inc stock is traded at $8.70, with a volume of 2.65M. It is up +2.11% in the last 24 hours and up +1.75% over the past month. Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.
See More
Previous Close:
$8.52
Open:
$8.6
24h Volume:
2.65M
Relative Volume:
0.44
Market Cap:
$1.41B
Revenue:
$1.08B
Net Income/Loss:
$422.82M
P/E Ratio:
3.8158
EPS:
2.28
Net Cash Flow:
$-637.33M
1W Performance:
-1.02%
1M Performance:
+1.75%
6M Performance:
+30.43%
1Y Performance:
-10.72%
1-Day Range:
Value
$8.52
$8.7535
1-Week Range:
Value
$8.19
$8.775
52-Week Range:
Value
$5.01
$11.55

Novavax Inc Stock (NVAX) Company Profile

Name
Name
Novavax Inc
Name
Phone
240-268-2000
Name
Address
700 QUINCE ORCHARD ROAD, GAITHERSBURG, MD
Name
Employee
1,992
Name
Twitter
@novavax
Name
Next Earnings Date
2024-11-07
Name
Latest SEC Filings
Name
NVAX's Discussions on Twitter

Compare NVAX with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
NVAX
Novavax Inc
8.70 1.38B 1.08B 422.82M -637.33M 2.28
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
420.17 108.04B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
478.58 60.75B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
585.31 61.26B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ARGX
Argen X Se Adr
829.83 50.32B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
164.02 33.75B 398.11M -1.03B -868.57M -5.7032

Novavax Inc Stock (NVAX) Upgrades & Downgrades

Date Action Analyst Rating Change
Oct-24-25 Resumed Cantor Fitzgerald Overweight
Aug-28-25 Resumed H.C. Wainwright Buy
Aug-20-25 Downgrade BofA Securities Neutral → Underperform
Jun-17-25 Initiated Citigroup Sell
Feb-28-25 Initiated BTIG Research Buy
Jul-30-24 Downgrade JP Morgan Neutral → Underweight
May-10-24 Upgrade BofA Securities Underperform → Neutral
May-10-24 Upgrade JP Morgan Underweight → Neutral
Aug-09-23 Upgrade B. Riley Securities Neutral → Buy
Apr-20-23 Downgrade TD Cowen Outperform → Market Perform
Mar-01-23 Downgrade B. Riley Securities Buy → Neutral
Jan-09-23 Reiterated B. Riley Securities Buy
Dec-30-22 Reiterated H.C. Wainwright Buy
Dec-02-22 Initiated Jefferies Hold
Sep-22-22 Downgrade JP Morgan Neutral → Underweight
May-20-22 Initiated BofA Securities Underperform
Feb-23-22 Reiterated B. Riley Securities Buy
Feb-22-22 Resumed Jefferies Buy
Jan-21-22 Initiated Cowen Outperform
May-12-21 Downgrade JP Morgan Overweight → Neutral
Dec-14-20 Initiated Jefferies Buy
Aug-06-20 Reiterated H.C. Wainwright Buy
Aug-05-20 Upgrade JP Morgan Neutral → Overweight
Aug-05-20 Downgrade Ladenburg Thalmann Neutral → Sell
Jul-16-20 Reiterated H.C. Wainwright Buy
Jul-08-20 Downgrade Ladenburg Thalmann Buy → Neutral
Jun-29-20 Reiterated B. Riley FBR Buy
Jun-29-20 Reiterated H.C. Wainwright Buy
Jun-05-20 Upgrade JP Morgan Underweight → Neutral
May-28-20 Reiterated B. Riley FBR Buy
May-12-20 Reiterated H.C. Wainwright Buy
Apr-30-20 Reiterated H.C. Wainwright Buy
Nov-27-19 Resumed B. Riley FBR Buy
Aug-14-19 Reiterated H.C. Wainwright Buy
Feb-28-19 Downgrade Piper Jaffray Overweight → Underweight
Dec-18-18 Initiated Ladenburg Thalmann Buy
Dec-11-18 Initiated Oppenheimer Outperform
Nov-26-18 Upgrade Piper Jaffray Neutral → Overweight
Sep-21-18 Upgrade JP Morgan Underweight → Overweight
Mar-29-18 Upgrade Seaport Global Securities Neutral → Buy
View All

Novavax Inc Stock (NVAX) Latest News

Novavax Inc Stock (NVAX) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Novavax Inc Stock (NVAX) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
Alton Gregg H
Director
Jun 12 '25
Option Exercise
0.00
10,420
0
28,805
King Rachel K.
Director
Jun 12 '25
Option Exercise
0.00
10,420
0
25,190
Rodgers Richard J
Director
Jun 12 '25
Option Exercise
0.00
10,420
0
24,690
MOTT DAVID M
Director
Jun 12 '25
Option Exercise
0.00
10,420
0
60,890
DOUGLAS RICHARD
Director
Jun 12 '25
Option Exercise
0.00
10,420
0
54,340
$37.26
price up icon 0.00%
$93.08
price up icon 1.97%
$29.03
price down icon 2.88%
$106.05
price up icon 0.37%
biotechnology ONC
$315.43
price up icon 1.49%
$164.02
price up icon 2.73%
Cap:     |  Volume (24h):